Profile
Dr. Ken E.
Drazan, MD, is a Chairman & Chief Executive Officer at Arsenal Biosciences, Inc. and a Surgeon at Stanford University.
Dr. Drazan was previously employed as a Chairman by ArgiNOx Pharmaceuticals, Inc., a Partner & co-founder by Bertram Capital Management LLC, an Executive Chairman by GENASCIS LLC, a President by GRAIL LLC, and a Basic Scientist by University of California, Los Angeles.
He received his undergraduate degree from Yale University and a doctorate degree from The State University of New York.
Ken Drazan active positions
| Companies | Position | Start |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Chief Executive Officer | 01/01/2019 |
Former positions of Ken Drazan
| Companies | Position | End |
|---|---|---|
| GRAIL, INC. | President | 01/08/2018 |
GENASCIS LLC
GENASCIS LLC Packaged SoftwareTechnology Services Provides revenue cycle management services for ambulatory surgery centers | Chairman | - |
Bertram Capital Management LLC
Bertram Capital Management LLC Investment ManagersFinance Bertram Capital Mgmt invests in middle-market companies located in the United States with an enterprise value of USD 50 - 500 million, an EBITDA of USD 5 - 35 million and revenues of USD 20 - 250 million. The firm focuses on sectors such as business services, consumer, industrial/manufacturing and technology. It participates in divestitures, MBO, shareholder liquidity events with an investment size of USD 25 - 250 million. The firm acquires controlling interests. | Private Equity Investor | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ArgiNOx Pharmaceuticals, Inc.
ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Founder | - |
Training of Ken Drazan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ArgiNOx Pharmaceuticals, Inc.
ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bertram Capital Management LLC
Bertram Capital Management LLC Investment ManagersFinance Bertram Capital Mgmt invests in middle-market companies located in the United States with an enterprise value of USD 50 - 500 million, an EBITDA of USD 5 - 35 million and revenues of USD 20 - 250 million. The firm focuses on sectors such as business services, consumer, industrial/manufacturing and technology. It participates in divestitures, MBO, shareholder liquidity events with an investment size of USD 25 - 250 million. The firm acquires controlling interests. | Finance |
GENASCIS LLC
GENASCIS LLC Packaged SoftwareTechnology Services Provides revenue cycle management services for ambulatory surgery centers | Technology Services |
GRAIL, Inc.
GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
- Stock Market
- Insiders
- Ken Drazan
















